Aker Solutions Awarded Contract for Chlorine Dioxide Plant in Russia

Aker Solutions has signed a contract with Ilim Group to supply an integrated chlorine dioxide plant for Ilim's pulp mill project in Bratsk, Russia. The contract value to Aker Solutions is approximately $18 million. Aker Solutions will supply technology, engineering, equipment, site and commissioning services from its office in Vancouver, Canada, with support from its office in Moscow.

The 15 ton/day integrated chlorine dioxide plant is scheduled for commissioning in 2012, and will complement Ilim's $700 million project to build a new, modern 720,000 ton/year pulp line at Ilim Group's existing Bratsk Mill.

The plant will utilize Aker Solutions' proprietary integrated chlorine dioxide process technology, which has been adopted by pulp mills around to world to gain production cost advantages and to reduce their dependence on external chemical suppliers.

"

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.